Financial Statements — CTXR
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 4.59 | 7.72 | 6.09 | 0.03 | 1.10 | 17.91 | 12.56 | 20.35 | 33.28 | 29.07 | 36.89 | 48.04 | 55.76 | 65.42 | 115.66 | 103.70 | 4.30 |
| Accounts Receivable | 1.08 | 4.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | 22.66 | 22.64 | 17.21 | 15.34 | 14.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 31.69 | 37.95 | 24.61 | 18.37 | 18.33 | 28.01 | 21.57 | 28.21 | 41.11 | 34.90 | 42.32 | 50.83 | 58.26 | 67.94 | 116.94 | 104.97 | 5.58 |
| Property, Plant & Equipment | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Goodwill | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 |
| Total Non-current Assets* | 100.85 | 102.45 | 103.07 | 103.11 | 102.38 | 69.08 | 69.14 | 69.19 | 69.29 | 69.34 | 69.39 | 69.48 | 69.53 | 69.57 | 29.66 | 29.69 | 29.73 |
| Total Assets | 132.54 | 140.39 | 127.68 | 121.48 | 120.70 | 97.09 | 90.71 | 97.40 | 110.40 | 104.24 | 111.71 | 120.32 | 127.79 | 137.52 | 146.59 | 134.67 | 35.31 |
| Accounts Payable | 9.45 | 11.02 | 10.09 | 9.37 | 7.36 | 1.66 | 2.67 | 2.65 | 3.08 | 2.73 | 1.54 | 1.69 | 1.71 | 1.79 | 1.35 | 1.13 | 0.98 |
| Total Current Liabilities | 55.02 | 38.21 | 51.84 | 49.88 | 44.81 | 4.15 | 4.17 | 5.58 | 5.79 | 6.21 | 4.54 | 4.46 | 4.02 | 7.34 | 3.60 | 2.98 | 3.55 |
| Total Non-current Liabilities* | 8.44 | 8.72 | 8.27 | 8.03 | 6.98 | 6.65 | 6.57 | 6.49 | 6.31 | 6.22 | 6.13 | 5.52 | 5.57 | 5.62 | 5.71 | 5.92 | 5.96 |
| Total Liabilities | 63.46 | 46.92 | 60.12 | 57.91 | 51.78 | 10.81 | 10.74 | 12.07 | 12.10 | 12.43 | 10.67 | 9.98 | 9.59 | 12.96 | 9.31 | 8.90 | 9.51 |
| Retained Earnings | (268.26) | (247.02) | (230.84) | (222.05) | (211.14) | (190.58) | (180.01) | (171.46) | (152.29) | (143.81) | (133.28) | (121.70) | (112.83) | (105.27) | (91.09) | (85.26) | (81.14) |
| Total Stockholder Equity* | 61.54 | 79.96 | 65.06 | 60.66 | 65.41 | 85.68 | 79.37 | 84.73 | 97.70 | 91.21 | 100.43 | 109.74 | 117.60 | 123.96 | 136.68 | 125.16 | 25.80 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Total Revenue | 1.67 | 3.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.09 | -- | -- | 0.00 | 0.09 |
| Cost of Revenue | 0.33 | 0.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 1.34 | 3.15 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 1.63 | 1.60 | 1.64 | 1.62 | 3.77 | 2.13 | 2.91 | 2.76 | 3.61 | 2.62 | 2.88 | 3.76 | 4.73 | 3.45 | 3.86 | 4.89 | 3.45 | 5.46 | 2.29 | 2.20 |
| Selling, General & Admin | 26.39 | 5.72 | 3.91 | 4.45 | 4.79 | 5.39 | 5.49 | 4.81 | 4.29 | 3.66 | 4.17 | 3.73 | 4.79 | 2.60 | 2.72 | 3.02 | 3.12 | 2.90 | 2.45 | 3.41 |
| Total Operating Expenses | 33.53 | 12.17 | 8.44 | 8.79 | 11.26 | 10.04 | 11.05 | 10.63 | 10.97 | 9.34 | 10.12 | 8.67 | 10.69 | 7.25 | 7.55 | 8.92 | 7.59 | 9.26 | 5.20 | 5.98 |
| Operating Income | (32.19) | (9.02) | (8.44) | (8.79) | (11.26) | (10.04) | (11.05) | (10.63) | (10.97) | (9.34) | (10.12) | (8.67) | (10.69) | (7.25) | (7.55) | (8.92) | (7.59) | (9.26) | (5.20) | (5.98) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 |
| Pretax Income | (28.34) | (9.13) | (8.48) | (8.94) | (11.25) | (10.02) | (10.93) | (10.43) | (8.40) | (9.09) | (9.80) | (8.34) | (10.38) | (3.45) | (7.41) | -- | -- | -- | -- | -- |
| Tax Provision | (0.23) | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | -- | -- | -- | -- | -0.00 | 0.00 |
| Net Income | (28.11) | (9.39) | (8.74) | (9.20) | (11.51) | (10.28) | (11.08) | (10.57) | (8.54) | (9.23) | (9.94) | (8.48) | (10.53) | (3.59) | (7.99) | (8.86) | (7.56) | (9.23) | (4.96) | (5.82) |
| Basic EPS | (0.95) | (0.38) | (0.01) | (0.80) | (1.27) | (1.30) | (1.61) | -- | -- | -- | -- | (0.06) | (0.07) | (0.02) | (0.05) | (0.06) | (0.05) | -- | -- | -- |
| Diluted EPS | (0.95) | (0.38) | (0.01) | (0.80) | (1.27) | (1.30) | (1.61) | -- | -- | -- | -- | (0.06) | (0.07) | (0.02) | (0.05) | (0.06) | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Operating Cash Flow | (1.30) | (13.01) | (11.88) | (5.41) | (4.54) | (4.73) | (5.91) | (8.37) | (7.79) | (6.14) | (6.80) | (9.58) | (7.85) | (4.82) | (6.33) | (7.71) | (9.67) | (4.65) | (5.59) | (4.82) |
| Capital Expenditures | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.01 |
| Free Cash Flow* | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (4.83) |
| Investing Cash Flow | (0.60) | (4.40) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (40.00) | (0.01) |
| Financing Cash Flow | (1.23) | 20.88 | 15.79 | 11.47 | 3.47 | 2.57 | (3.75) | 13.72 | -- | -- | -0.00 | 13.80 | 0.03 | -- | -- | -- | -- | -- | 0.00 | 16.80 |
* Derived from reported values
